# Breast Cancer Histopathology Classification using CBAM-EfficientNetV2 with Transfer Learning

arXiv: https://arxiv.org/abs/2410.22392 · HTML: https://mlsanity.com/paper/2410.22392/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 7 of its 35 references that are in the map.
- First posted on arXiv 29 Oct 2024.

## Builds on (most cited first, 7 of 7)

- [Attention Is All You Need](https://mlsanity.com/paper/1706.03762/) (2017)
- [EfficientNet: Rethinking Model Scaling for Convolutional Neural Networks](https://mlsanity.com/paper/1905.11946/) (2019)
- [CBAM: Convolutional Block Attention Module](https://mlsanity.com/paper/1807.06521/) (2018)
- [Deformable Convolutional Networks](https://mlsanity.com/paper/1703.06211/) (2017)
- [A Survey on Deep Learning in Medical Image Analysis](https://mlsanity.com/paper/1702.05747/) (2017)
- [Transfusion: Understanding Transfer Learning for Medical Imaging](https://mlsanity.com/paper/1902.07208/) (2019)
- [A Survey on Negative Transfer](https://mlsanity.com/paper/2009.00909/) (2020)

## Abstract (arXiv)

Breast cancer histopathology image classification is critical for early detection and improved patient outcomes. 1 This study introduces a novel approach leveraging EfficientNetV2 models, to improve feature extraction and focus on relevant tissue regions. The proposed models were evaluated on the BreakHis dataset across multiple magnification scales (40X, 100X, 200X, and 400X). 2 Among them, the EfficientNetV2-XL with CBAM achieved outstanding performance, reaching a peak accuracy of 99.01 percent and an F1-score of 98.31 percent at 400X magnification, outperforming state-of-the-art methods. 3 By integrating Contrast Limited Adaptive Histogram Equalization (CLAHE) for preprocessing and optimizing computational efficiency, this method demonstrates its suitability for real-time clinical deployment. 3 The results underscore the potential of attention-enhanced scalable architectures in advancing diagnostic precision for breast cancer detection.